843 related articles for article (PubMed ID: 10071266)
1. Clinical presentation, course, and prognostic factors in lymphocyte-predominant Hodgkin's disease and lymphocyte-rich classical Hodgkin's disease: report from the European Task Force on Lymphoma Project on Lymphocyte-Predominant Hodgkin's Disease.
Diehl V; Sextro M; Franklin J; Hansmann ML; Harris N; Jaffe E; Poppema S; Harris M; Franssila K; van Krieken J; Marafioti T; Anagnostopoulos I; Stein H
J Clin Oncol; 1999 Mar; 17(3):776-83. PubMed ID: 10071266
[TBL] [Abstract][Full Text] [Related]
2. European Task Force on Lymphoma project on lymphocyte predominance Hodgkin disease: histologic and immunohistologic analysis of submitted cases reveals 2 types of Hodgkin disease with a nodular growth pattern and abundant lymphocytes.
Anagnostopoulos I; Hansmann ML; Franssila K; Harris M; Harris NL; Jaffe ES; Han J; van Krieken JM; Poppema S; Marafioti T; Franklin J; Sextro M; Diehl V; Stein H
Blood; 2000 Sep; 96(5):1889-99. PubMed ID: 10961891
[TBL] [Abstract][Full Text] [Related]
3. Lymphocyte predominant Hodgkin's disease: pathology and clinical implication.
Franklin J; Tesch H; Hansmann ML; Diehl V
Ann Oncol; 1998; 9 Suppl 5():S39-44. PubMed ID: 9926236
[TBL] [Abstract][Full Text] [Related]
4. Lymphocyte predominant Hodgkin's disease--a workshop report. European Task Force on Lymphoma.
Sextro M; Diehl V; Franklin J; Hansmann ML; Anagnostopoulos I; Marafioti T; Stein H
Ann Oncol; 1996; 7 Suppl 4():61-5. PubMed ID: 8836412
[TBL] [Abstract][Full Text] [Related]
5. Clinical presentation and outcome in lymphocyte-predominant Hodgkin's disease.
Bodis S; Kraus MD; Pinkus G; Silver B; Kadin ME; Canellos GP; Shulman LN; Tarbell NJ; Mauch PM
J Clin Oncol; 1997 Sep; 15(9):3060-6. PubMed ID: 9294468
[TBL] [Abstract][Full Text] [Related]
6. Hodgkin's disease with lymphocyte predominance: long-term results based on current histopathologic criteria.
Ha CS; Kavadi V; Dimopoulos MA; Hagemeister FB; Osborne BM; Fuller LM; Smith TL; Hess MA; McLaughlin PW; Cabanillas FF; Cox JD
Int J Radiat Oncol Biol Phys; 1999 Jan; 43(2):329-34. PubMed ID: 10030257
[TBL] [Abstract][Full Text] [Related]
7. Lymphocyte-predominant Hodgkin's disease. An immunohistochemical analysis of 208 reviewed Hodgkin's disease cases from the German Hodgkin Study Group.
von Wasielewski R; Werner M; Fischer R; Hansmann ML; Hübner K; Hasenclever D; Franklin J; Sextro M; Diehl V; Georgii A
Am J Pathol; 1997 Mar; 150(3):793-803. PubMed ID: 9060817
[TBL] [Abstract][Full Text] [Related]
8. [Combined-modality therapy for 150 cases of early-stage Hodgkin's lymphoma].
Niu Y; Shi YK; He XH; Feng FY; Zhou LQ; Gu DZ
Zhonghua Zhong Liu Za Zhi; 2008 Aug; 30(8):630-4. PubMed ID: 19102946
[TBL] [Abstract][Full Text] [Related]
9. Lymphocyte-rich classical Hodgkin's lymphoma: clinical presentation and treatment outcome in 100 patients treated within German Hodgkin's Study Group trials.
Shimabukuro-Vornhagen A; Haverkamp H; Engert A; Balleisen L; Majunke P; Heil G; Eich HT; Stein H; Diehl V; Josting A
J Clin Oncol; 2005 Aug; 23(24):5739-45. PubMed ID: 16009944
[TBL] [Abstract][Full Text] [Related]
10. Simultaneous lymphocyte predominant Hodgkin's disease and large-cell lymphoma.
Grossman DM; Hanson CA; Schnitzer B
Am J Surg Pathol; 1991 Jul; 15(7):668-76. PubMed ID: 2058762
[TBL] [Abstract][Full Text] [Related]
11. [Feasibility study of application of international prognostic score on prediction of prognosis for advanced Hodgkin's lymphoma].
Fu XH; Wang SS; Huang Y; Wang B; Huang HQ; Zhang L; Sun XF; Xu RH; Lin TY
Ai Zheng; 2006 Aug; 25(8):1013-8. PubMed ID: 16965685
[TBL] [Abstract][Full Text] [Related]
12. Lymphocyte predominant Hodgkin's disease.
Ekstrand BC; Horning SJ
Curr Oncol Rep; 2002 Sep; 4(5):424-33. PubMed ID: 12162918
[TBL] [Abstract][Full Text] [Related]
13. Nodular lymphocyte-predominant Hodgkin's lymphoma.
Nogovà L; Diehl V; Engert A;
Curr Hematol Malig Rep; 2006 Mar; 1(1):60-5. PubMed ID: 20425333
[TBL] [Abstract][Full Text] [Related]
14. Lymphocyte predominance Hodgkin's disease: a reappraisal based upon histological and immunophenotypical findings in relapsing cases.
Regula DP; Weiss LM; Warnke RA; Dorfman RF
Histopathology; 1987 Nov; 11(11):1107-20. PubMed ID: 3692445
[TBL] [Abstract][Full Text] [Related]
15. Extranodal lymphocyte predominance Hodgkin's disease. Clinical and pathologic features.
Siebert JD; Stuckey JH; Kurtin PJ; Banks PM
Am J Clin Pathol; 1995 Apr; 103(4):485-91. PubMed ID: 7726148
[TBL] [Abstract][Full Text] [Related]
16. [A retrospective analysis of the treatment results in Hodgkin's disease in a radiotherapy clinic].
Mjaaland I; Ganser D; Freitag EM; Bohndorf W
Strahlenther Onkol; 1994 Sep; 170(9):516-23. PubMed ID: 7524173
[TBL] [Abstract][Full Text] [Related]
17. Mantle irradiation alone for pathologic stage I and II Hodgkin's disease: long-term follow-up and patterns of failure.
Liao Z; Ha CS; Vlachaki MT; Hagemeister F; Cabanillas F; Hess M; Tucker S; Cox JD
Int J Radiat Oncol Biol Phys; 2001 Jul; 50(4):971-7. PubMed ID: 11429225
[TBL] [Abstract][Full Text] [Related]
18. Nodular type of lymphocyte predominant Hodgkin's disease. A clinical study of 50 cases.
Pappa VI; Norton AJ; Gupta RK; Wilson AM; Rohatiner AZ; Lister TA
Ann Oncol; 1995 Jul; 6(6):559-65. PubMed ID: 8573534
[TBL] [Abstract][Full Text] [Related]
19. Nodular lymphocyte predominant Hodgkin's lymphoma.
Siddiqui N; Al-Diab AI
Saudi Med J; 2005 Feb; 26(2):241-5. PubMed ID: 15770298
[TBL] [Abstract][Full Text] [Related]
20. Lymphocyte predominance Hodgkin's disease: the use of bcl-6 and CD57 in diagnosis and differential diagnosis.
Kraus MD; Haley J
Am J Surg Pathol; 2000 Aug; 24(8):1068-78. PubMed ID: 10935647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]